These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20739292)

  • 1. Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice.
    Lefterov I; Fitz NF; Cronican AA; Fogg A; Lefterov P; Kodali R; Wetzel R; Koldamova R
    J Biol Chem; 2010 Nov; 285(47):36945-57. PubMed ID: 20739292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
    Lewis TL; Cao D; Lu H; Mans RA; Su YR; Jungbauer L; Linton MF; Fazio S; LaDu MJ; Li L
    J Biol Chem; 2010 Nov; 285(47):36958-68. PubMed ID: 20847045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of apolipoprotein A-I decreases parenchymal and vascular β-amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Contu L; Carare RO; Hawkes CA
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):698-714. PubMed ID: 31002190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.
    Liao F; Hori Y; Hudry E; Bauer AQ; Jiang H; Mahan TE; Lefton KB; Zhang TJ; Dearborn JT; Kim J; Culver JP; Betensky R; Wozniak DF; Hyman BT; Holtzman DM
    J Neurosci; 2014 May; 34(21):7281-92. PubMed ID: 24849360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice.
    Willem M; Dewachter I; Smyth N; Van Dooren T; Borghgraef P; Haass C; Van Leuven F
    Am J Pathol; 2004 Nov; 165(5):1621-31. PubMed ID: 15509532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic ablation of apolipoprotein A-IV accelerates Alzheimer's disease pathogenesis in a mouse model.
    Cui Y; Huang M; He Y; Zhang S; Luo Y
    Am J Pathol; 2011 Mar; 178(3):1298-308. PubMed ID: 21356380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
    Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
    J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP/PS1 transgenic mice.
    Weitz TM; Gate D; Rezai-Zadeh K; Town T
    Am J Pathol; 2014 Nov; 184(11):2855-61. PubMed ID: 25174876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.
    Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T
    J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.